Eagle Pharmaceuticals (EGRX) Short Interest Ratio & Short Volume → Elon’s New Device is About to Shock the World (From InvestorPlace) (Ad) Free EGRX Stock Alerts $4.76 +0.01 (+0.21%) (As of 05/17/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Eagle Pharmaceuticals Short Interest DataCurrent Short Volume1,200,000 sharesPrevious Short Volume1,180,000 sharesChange Vs. Previous Month+1.69%Dollar Volume Sold Short$4.91 millionShort Interest Ratio / Days to Cover7.7Last Record DateApril 30, 2024Outstanding Shares12,990,000 sharesFloat Size11,430,000 sharesShort Percent of Float10.50%Today's Trading Volume68,384 sharesAverage Trading Volume118,483 sharesToday's Volume Vs. Average58% Short Selling Eagle Pharmaceuticals ? Sign up to receive the latest short interest report for Eagle Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatEGRX Short Interest Over TimeEGRX Days to Cover Over TimeEGRX Percentage of Float Shorted Over Time Ad InvestorPlaceBible Shocker: Have You Seen Elon Musk’s Miracle?Breaking News: Elon Musk Invents New Type of A.I. (Shocking) Elon Musk is about to shock the world again with this new type of A.I.… Minting new millionaires in the process.Click here for the full story… Eagle Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20241,200,000 shares $4.91 million +1.7%10.5%7.7 $4.09 4/15/20241,180,000 shares $6.14 million -2.5%10.3%5.9 $5.20 3/31/20241,210,000 shares $6.34 million +4.3%10.6%5.3 $5.24 3/15/20241,160,000 shares $7.02 million +4.5%10.2%5 $6.05 2/29/20241,110,000 shares $6.50 million +4.7%9.7%4.3 $5.86 2/15/20241,060,000 shares $6.20 million +33.2%9.3%3.6 $5.85 Get the Latest News and Ratings for EGRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Eagle Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 1/31/2024796,100 shares $4.67 million +10.1%7.0%2.8 $5.86 1/15/2024723,100 shares $3.28 million +3.7%6.4%2.9 $4.53 12/31/2023697,400 shares $3.65 million +3.9%6.2%3.4 $5.23 12/15/2023671,300 shares $3.11 million +13.7%5.9%3.6 $4.63 11/30/2023590,400 shares $3.45 million -0.7%5.2%3.9 $5.85 11/15/2023594,600 shares $5.25 million -3.7%5.2%5.2 $8.83 10/31/2023617,600 shares $8.48 million +2.4%5.5%5.8 $13.73 10/15/2023602,900 shares $8.10 million +12.5%5.3%4.9 $13.43 9/30/2023536,000 shares $8.45 million -23.9%4.7%4.1 $15.77 9/15/2023704,600 shares $11.42 million +9.9%6.2%5.2 $16.21 8/31/2023640,900 shares $10.86 million -6.1%5.7%3.3 $16.95 8/15/2023682,400 shares $11.63 million +4.5%6.0%3.4 $17.04 7/31/2023653,200 shares $13.56 million -4.0%5.7%3.2 $20.76 7/15/2023680,200 shares $12.50 million +14.6%6.0%3.6 $18.37 6/30/2023593,600 shares $11.54 million -26.9%5.2%3.2 $19.44 6/15/2023812,500 shares $15.41 million +18.6%7.1%4.2 $18.96 5/31/2023685,200 shares $14.22 million -1.3%6.0%4.1 $20.75 5/15/2023694,400 shares $14.60 million -3.0%6.1%4.3 $21.03 4/30/2023715,700 shares $20.10 million -5.1%6.3%4.7 $28.08 4/15/2023754,400 shares $22.41 million -19.7%6.7%4.8 $29.71 3/31/2023939,300 shares $26.65 million -7.9%8.3%5.5 $28.37 3/15/20231,020,000 shares $26.27 million +16.4%9.0%6.3 $25.75 2/28/2023876,100 shares $24.53 million +1.0%7.8%6.1 $28.00 2/15/2023867,400 shares $26.73 million -0.8%7.7%6.3 $30.82 1/31/2023874,400 shares $29.68 million -9.7%7.7%5.8 $33.94 1/15/2023968,700 shares $31.43 million -2.4%8.6%6.2 $32.45 12/30/2022992,100 shares $29.00 million +63.8%8.8%6.4 $29.23 12/15/2022605,700 shares $17.90 million -27.0%5.4%3.6 $29.55 11/30/2022830,100 shares $30.15 million -9.4%7.3%4.9 $36.32 11/15/2022915,900 shares $33.89 million +0.1%8.1%5.3 $37.00 10/31/2022915,200 shares $28.80 million -6.5%8.1%4.9 $31.47 10/15/2022978,700 shares $27.01 million +8.4%8.5%5.6 $27.60 9/30/2022903,200 shares $23.86 million +28.8%7.8%5.4 $26.42 9/15/2022701,400 shares $21.13 million -17.2%6.1%4.3 $30.12The Overlooked Retirement Asset You Probably Don’t Own (Ad)4 out of 5 Americans believe we’re on the brink of a retirement crisis. Luckily, in these unprecedented times, we have an unprecedented solution. Once considered a “fringe” investment, the crypto market is now taking the world by storm.Click here to access the Crypto Retirement Blueprint now. EGRX Short Interest - Frequently Asked Questions What is Eagle Pharmaceuticals' current short interest? Short interest is the volume of Eagle Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 1,200,000 shares of EGRX short. 10.50% of Eagle Pharmaceuticals' shares are currently sold short. Learn More on Eagle Pharmaceuticals' current short interest. What is a good short interest ratio for Eagle Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. EGRX shares currently have a short interest ratio of 8.0. Learn More on Eagle Pharmaceuticals's short interest ratio. What is a good short interest percentage for Eagle Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 10.50% of Eagle Pharmaceuticals' floating shares are currently sold short. Is Eagle Pharmaceuticals' short interest increasing or decreasing? Eagle Pharmaceuticals saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 1,200,000 shares, an increase of 1.7% from the previous total of 1,180,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Eagle Pharmaceuticals' float size? Eagle Pharmaceuticals currently has issued a total of 12,990,000 shares. Some of Eagle Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Eagle Pharmaceuticals currently has a public float of 11,430,000 shares. How does Eagle Pharmaceuticals' short interest compare to its competitors? 10.50% of Eagle Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Eagle Pharmaceuticals: Carisma Therapeutics, Inc. (9.41%), Kronos Bio, Inc. (1.71%), CalciMedica, Inc. (0.93%), Anebulo Pharmaceuticals, Inc. (0.19%), Immix Biopharma, Inc. (2.80%), Eledon Pharmaceuticals, Inc. (0.14%), Mural Oncology plc (11.13%), Tiziana Life Sciences Ltd (0.38%), Kezar Life Sciences, Inc. (5.70%), Checkpoint Therapeutics, Inc. (11.50%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Eagle Pharmaceuticals stock? Short selling EGRX is an investing strategy that aims to generate trading profit from Eagle Pharmaceuticals as its price is falling. EGRX shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Eagle Pharmaceuticals? A short squeeze for Eagle Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of EGRX, which in turn drives the price of the stock up even further. How often is Eagle Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EGRX, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: CARM Short Squeeze KRON Short Squeeze CALC Short Squeeze ANEB Short Squeeze IMMX Short Squeeze ELDN Short Squeeze MURA Short Squeeze TLSA Short Squeeze KZR Short Squeeze CKPT Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:EGRX) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersBuy this small stock before coming AI Tidal WaveChaikin AnalyticsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingDems have chosen Biden replacement?Paradigm PressForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the MarketsShocking $16T Elon Musk Crypto LeakCrypto 101 MediaExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersA letter is coming from the "Bureau of the Fiscal Service".Stansberry ResearchHow Biden has already won 2024Porter & Company